Abstract
CPT1A enzyme deficiency is a rare metabolic disorder of mitochondrial fatty acid oxidation, with late manifestations during infancy or childhood, including hypoketotic hypoglycemia and hepatic encephalopathy. Newborn screening in several countries include pre-symptomatic detection of CPT1A deficiency, which helps in early diagnosis and better management of the disorder. We report here a case of CPT1A deficiency, detected pre-symptomatically with newborn screening, which was confirmed by exome sequencing to be a novel c. 232G>A variant in exon 3 of CPT1A gene. This is a rare variant of uncertain significance which has not been reported in literature.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
